Mi-Jin Cho
Direktor/Vorstandsmitglied bei SK BIOSCIENCE CO.,LTD.
Ursprung des Netzwerks ersten Grades von Mi-Jin Cho
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mi-Jin Cho
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Seoul National University | College/University | Graduate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
Korea University | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
SK CHEMICALS CO.,LTD | Chemicals: Specialty | Chief Executive Officer Investor Relations Contact | |
The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
Yonsei University | College/University | Undergraduate Degree Undergraduate Degree | |
SK GAS CO., LTD. | Gas Distributors | Director/Board Member Investor Relations Contact | |
Ajou University | College/University | Doctorate Degree | |
University of London | College/University | Doctorate Degree | |
Berkeley Law University of California | College/University | Graduate Degree | |
Ewha Womans University | College/University | Graduate Degree | |
Konkuk University | College/University | Undergraduate Degree | |
Hanyang University | College/University | Masters Business Admin | |
Kyonggi University | College/University | Graduate Degree | |
Sungkyunkwan University | College/University | Graduate Degree | |
HANWHA CORPORATION | Industrial Specialties | Director/Board Member | |
Daishin Securities Co., Ltd. (Broker)
Daishin Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Daishin Securities Co., Ltd. (Broker) is the securities brokerage division of Daishin Securities Co., Ltd. (KRX: 003540), a financial services firm headquartered in Seoul, South Korea. Founded in 1962, the firm provides broking services to various investors. | Investment Banks/Brokers | Analyst-Equity | |
SK DISCOVERY CO., LTD. | Pharmaceuticals: Major | Investor Relations Contact | |
Indiana University | College/University | Masters Business Admin | |
CGS-CIMB Securities (Hong Kong) Ltd.
CGS-CIMB Securities (Hong Kong) Ltd. Investment Banks/BrokersFinance CGS-CIMB Securities (Hong Kong) Ltd. is a subsidiary of CIMB Group, the leading ASEAN Universal Bank. The company is based in Hong Kong, Hong Kong. The Chinese company provides efficient regional banking solutions for personal and business financial needs. The company has taken various precautionary measures to protect the health of their customers, employees, businesses, and communities during the Covid-19 outbreak. Ultimately, the company is controlled by the Government of China. The company was founded in 1991, and Soo Lik Keoy has been the CEO of the company since 2010. | Investment Banks/Brokers | Analyst-Equity | |
University of California, Berkeley | College/University | Masters Business Admin | |
UBCARE. CO., LTD. | Packaged Software | Comptroller/Controller/Auditor | |
DONG-A SOCIO HOLDINGS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
E-MART INC. | Department Stores | Director/Board Member | |
CJ CHEILJEDANG CORPORATION | Air Freight/Couriers | Director/Board Member | |
Hana Securities Co., Ltd. (Broker)
Hana Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Hana Securities Co., Ltd. (Broker) (Hana Securities-Broker) is the securities brokerage division of Hana Securities Co., Ltd., which is owned by Hana Financial Group, Inc. (KRX: 086790) in Korea. The firm was founded in 1977 as Daehan Investment & Securities Co. Ltd. (until 2007), as Hana Daetoo Securities Co., Ltd. (until 2015) and as Hana Financial Investment Co., Ltd. (until 2022). Headquartered in Seoul, Hana Securities-Broker offers trading and execution services to various clients. | Investment Banks/Brokers | Analyst-Equity | |
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Corporate Officer/Principal |
Statistik
International
Südkorea | 21 |
Vereinigte Staaten | 5 |
Vereinigtes Königreich | 3 |
Hong Kong | 2 |
Sektoral
Consumer Services | 15 |
Process Industries | 4 |
Finance | 4 |
Health Technology | 4 |
Utilities | 2 |
Operativ
Director/Board Member | 12 |
Graduate Degree | 9 |
Independent Dir/Board Member | 7 |
Undergraduate Degree | 7 |
Masters Business Admin | 5 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Gwang-Hyun Jeon | 7 |
Chang-Jin Moon | 6 |
Young-Joo Park | 6 |
Jeffrey Choi | 5 |
Jae-Yong An | 4 |
Ji-Hyun Yoo | 4 |
Hun Kim | 3 |
Ik-Hwan Kwon | 3 |
Yong-Sung Choi | 3 |
Su-Ahn Yoo | 3 |
Harry Kleanthous | 3 |
Jong-Gu Park | 2 |
Sally Choe | 1 |
- Börse
- Insiders
- Mi-Jin Cho
- Unternehmensverbindungen